verve records - Search News

News

Eli Lilly nears $1.3B deal for Verve Therapeutics

Barron's on MSN · 23h

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

UPI on MSN · 18h

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

Pharmaceutical Technology · 3h

Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn.

1h

Lock In The 81.5% Run: Initiating Verve With A Sell

Eli Lilly's $1.3B acquisition of Verve Therapeutics caused a sharp rally, but with shares above the buyout price, I recommend ...

Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

21hon MSN

Why Verve Therapeutics Stock Is Skyrocketing Today

Eli Lilly plans to acquire Verve for up to $1.3 billion. Shares of Verve Therapeutics (NASDAQ: VERV) were skyrocketing 75.7% ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results